Industry: Chemical & Material
Published Date: 2026-01-05
Pages: 94 Pages
Report ld: 5510588
Request Sample
Customized Report
High Purity Taxifolin Market Size(US$)

CAGR 2026-2032
4.1%
Market Size,2032
USD 36.97
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for High Purity Taxifolin was estimated to be worth US$ 28.09 million in 2025 and is projected to reach US$ 36.97 million, growing at a CAGR of 4.1% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on High Purity Taxifolin cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Taxifolin, also known as dihydroquercetin, is a natural flavonoid found in various plants such as Siberian larch, milk thistle, and onions. It is known for its potent antioxidant, anti-inflammatory, and anti-aging properties, making it a popular ingredient in dietary supplements and skincare products. Structurally related to the well-known flavonoid quercetin, taxifolin offers better water solubility and stability, which enhances its bioavailability and therapeutic potential. Research suggests it may support cardiovascular health, improve immune function, and protect cells from oxidative stress. High purity taxifolin in this report refers product with purity not less than 92%.
The market for taxifolin is primarily driven by growing consumer demand for natural antioxidants and health-promoting supplements, as awareness of chronic diseases and oxidative stress-related conditions increases globally. Its rising use in the pharmaceutical, nutraceutical, and cosmetic industries is fueled by its proven antioxidant, anti-inflammatory, and cardiovascular benefits. Additionally, the shift toward plant-based and clean-label ingredients in functional foods and beverages further boosts demand. Regulatory approvals and ongoing research validating its efficacy also contribute to market growth, positioning taxifolin as a key ingredient in the expanding wellness and preventive healthcare sectors.
This report provides a comprehensive view of the global market for High Purity Taxifolin, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The High Purity Taxifolin market size, estimations, and forecasts are presented in terms of sales volume (kg) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding High Purity Taxifolin.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the High Purity Taxifolin manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents High Purity Taxifolin sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents High Purity Taxifolin sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 High Purity Taxifolin Product Introduction
1.2 Global High Purity Taxifolin Market Size Forecast
1.2.1 Global High Purity Taxifolin Sales Value (2021–2032)
1.2.2 Global High Purity Taxifolin Sales Volume (2021–2032)
1.2.3 Global High Purity Taxifolin Sales Price (2021–2032)
1.3 High Purity Taxifolin Market Trends & Drivers
1.3.1 High Purity Taxifolin Industry Trends
1.3.2 High Purity Taxifolin Market Drivers & Opportunities
1.3.3 High Purity Taxifolin Market Challenges
1.3.4 High Purity Taxifolin Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global High Purity Taxifolin Players Revenue Ranking (2025)
2.2 Global High Purity Taxifolin Revenue by Company (2021–2026)
2.3 Global High Purity Taxifolin Sales Volume Ranking of Players (2025)
2.4 Global High Purity Taxifolin Sales Volume by Company (2021–2026)
2.5 Global High Purity Taxifolin Average Price by Company (2021–2026)
2.6 Key Manufacturers High Purity Taxifolin Manufacturing Base and Headquarters
2.7 Key Manufacturers High Purity Taxifolin Product Offerings
2.8 Key Manufacturers Start of Mass Production of High Purity Taxifolin
2.9 High Purity Taxifolin Market Competitive Analysis
2.9.1 High Purity Taxifolin Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by High Purity Taxifolin Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on High Purity Taxifolin revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation High Purity Taxifolin Market Classification
3.1 Introduction by Type
3.1.1 92%- 98%
3.1.2 Above 98%
3.1.3 Global High Purity Taxifolin Sales Value by Type
3.1.3.1 Global High Purity Taxifolin Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global High Purity Taxifolin Sales Value, by Type (2021–2032)
3.1.3.3 Global High Purity Taxifolin Sales Value, by Type (%), 2021–2032
3.1.4 Global High Purity Taxifolin Sales Volume by Type
3.1.4.1 Global High Purity Taxifolin Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global High Purity Taxifolin Sales Volume, by Type (2021–2032)
3.1.4.3 Global High Purity Taxifolin Sales Volume, by Type (%), 2021–2032
3.1.5 Global High Purity Taxifolin Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Healthcare
4.1.2 Food and Beverage
4.1.3 Cosmetics
4.1.4 Others
4.2 Global High Purity Taxifolin Sales Value by Application
4.2.1 Global High Purity Taxifolin Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global High Purity Taxifolin Sales Value, by Application (2021–2032)
4.2.3 Global High Purity Taxifolin Sales Value, by Application (%), 2021–2032
4.3 Global High Purity Taxifolin Sales Volume by Application
4.3.1 Global High Purity Taxifolin Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global High Purity Taxifolin Sales Volume, by Application (2021–2032)
4.3.3 Global High Purity Taxifolin Sales Volume, by Application (%), 2021–2032
4.4 Global High Purity Taxifolin Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global High Purity Taxifolin Sales Value by Region
5.1.1 Global High Purity Taxifolin Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global High Purity Taxifolin Sales Value by Region (2021–2026)
5.1.3 Global High Purity Taxifolin Sales Value by Region (2027–2032)
5.1.4 Global High Purity Taxifolin Sales Value by Region (%), 2021–2032
5.2 Global High Purity Taxifolin Sales Volume by Region
5.2.1 Global High Purity Taxifolin Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global High Purity Taxifolin Sales Volume by Region (2021–2026)
5.2.3 Global High Purity Taxifolin Sales Volume by Region (2027–2032)
5.2.4 Global High Purity Taxifolin Sales Volume by Region (%), 2021–2032
5.3 Global High Purity Taxifolin Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America High Purity Taxifolin Sales Value, 2021–2032
5.4.2 North America High Purity Taxifolin Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe High Purity Taxifolin Sales Value, 2021–2032
5.5.2 Europe High Purity Taxifolin Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific High Purity Taxifolin Sales Value, 2021–2032
5.6.2 Asia Pacific High Purity Taxifolin Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America High Purity Taxifolin Sales Value, 2021–2032
5.7.2 South America High Purity Taxifolin Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa High Purity Taxifolin Sales Value, 2021–2032
5.8.2 Middle East & Africa High Purity Taxifolin Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions High Purity Taxifolin Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions High Purity Taxifolin Sales Value and Sales Volume
6.2.1 Key Countries/Regions High Purity Taxifolin Sales Value, 2021–2032
6.2.2 Key Countries/Regions High Purity Taxifolin Sales Volume, 2021–2032
6.3 United States
6.3.1 United States High Purity Taxifolin Sales Value, 2021–2032
6.3.2 United States High Purity Taxifolin Sales Value by Type (%), 2025 vs 2032
6.3.3 United States High Purity Taxifolin Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe High Purity Taxifolin Sales Value, 2021–2032
6.4.2 Europe High Purity Taxifolin Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe High Purity Taxifolin Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China High Purity Taxifolin Sales Value, 2021–2032
6.5.2 China High Purity Taxifolin Sales Value by Type (%), 2025 vs 2032
6.5.3 China High Purity Taxifolin Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan High Purity Taxifolin Sales Value, 2021–2032
6.6.2 Japan High Purity Taxifolin Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan High Purity Taxifolin Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea High Purity Taxifolin Sales Value, 2021–2032
6.7.2 South Korea High Purity Taxifolin Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea High Purity Taxifolin Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia High Purity Taxifolin Sales Value, 2021–2032
6.8.2 Southeast Asia High Purity Taxifolin Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia High Purity Taxifolin Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India High Purity Taxifolin Sales Value, 2021–2032
6.9.2 India High Purity Taxifolin Sales Value by Type (%), 2025 vs 2032
6.9.3 India High Purity Taxifolin Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Ametis JSC
7.1.1 Ametis JSC Company Information
7.1.2 Ametis JSC Introduction and Business Overview
7.1.3 Ametis JSC High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Ametis JSC High Purity Taxifolin Product Offerings
7.1.5 Ametis JSC Recent Developments
7.2 Jilin Jianwei Natural Biotechnology
7.2.1 Jilin Jianwei Natural Biotechnology Company Information
7.2.2 Jilin Jianwei Natural Biotechnology Introduction and Business Overview
7.2.3 Jilin Jianwei Natural Biotechnology High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Jilin Jianwei Natural Biotechnology High Purity Taxifolin Product Offerings
7.2.5 Jilin Jianwei Natural Biotechnology Recent Developments
7.3 Kalenika Group
7.3.1 Kalenika Group Company Information
7.3.2 Kalenika Group Introduction and Business Overview
7.3.3 Kalenika Group High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Kalenika Group High Purity Taxifolin Product Offerings
7.3.5 Kalenika Group Recent Developments
7.4 ROBIOS
7.4.1 ROBIOS Company Information
7.4.2 ROBIOS Introduction and Business Overview
7.4.3 ROBIOS High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 ROBIOS High Purity Taxifolin Product Offerings
7.4.5 ROBIOS Recent Developments
7.5 Xi'an Sost Biotech Co.,Ltd
7.5.1 Xi'an Sost Biotech Co.,Ltd Company Information
7.5.2 Xi'an Sost Biotech Co.,Ltd Introduction and Business Overview
7.5.3 Xi'an Sost Biotech Co.,Ltd High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Xi'an Sost Biotech Co.,Ltd High Purity Taxifolin Product Offerings
7.5.5 Xi'an Sost Biotech Co.,Ltd Recent Developments
7.6 Focusherb
7.6.1 Focusherb Company Information
7.6.2 Focusherb Introduction and Business Overview
7.6.3 Focusherb High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Focusherb High Purity Taxifolin Product Offerings
7.6.5 Focusherb Recent Developments
7.7 Hoycome
7.7.1 Hoycome Company Information
7.7.2 Hoycome Introduction and Business Overview
7.7.3 Hoycome High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Hoycome High Purity Taxifolin Product Offerings
7.7.5 Hoycome Recent Developments
7.8 Herbchem Biotech
7.8.1 Herbchem Biotech Company Information
7.8.2 Herbchem Biotech Introduction and Business Overview
7.8.3 Herbchem Biotech High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Herbchem Biotech High Purity Taxifolin Product Offerings
7.8.5 Herbchem Biotech Recent Developments
8 Industry Chain Analysis
8.1 High Purity Taxifolin Industrial Chain
8.2 High Purity Taxifolin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 High Purity Taxifolin Sales Model
8.5.2 Sales Channels
8.5.3 High Purity Taxifolin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global High Purity Taxifolin market size was US$ 28.09 million in 2025 and is forecast to reach a readjusted size of US$ 36.97 million by 2032 with a CAGR of 4.1% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 80
USD 4250.00
(Single User License)
The global High Purity Taxifolin market was valued at US$ 28.09 million in 2025 and is anticipated to reach US$ 36.97 million by 2032, at a CAGR of 4.1% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 133
USD 2900.00
(Single User License)
The global High Purity Taxifolin market size was US$ 26.7 million in 2024 and is forecast to a readjusted size of US$ 35.7 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 80
USD 4250.00
(Single User License)
The global High Purity Taxifolin market is projected to grow from US$ 26.7 million in 2024 to US$ 35.7 million by 2031, at a CAGR of 4.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 150
USD 4900.00
(Single User License)
The global High Purity Taxifolin market is projected to grow from US$ 28.1 million in 2025 to US$ 35.7 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.1% during the forecast period.
Published Date: 2025-05-23
Pages: 134
USD 4900.00
(Single User License)
The global market for High Purity Taxifolin was valued at US$ 26.7 million in the year 2024 and is projected to reach a revised size of US$ 35.7 million by 2031, growing at a CAGR of 4.1% during the forecast period.
Published Date: 2025-05-23
Pages: 88
USD 2900.00
(Single User License)
The global market for High Purity Taxifolin was estimated to be worth US$ 26.7 million in 2024 and is forecast to a readjusted size of US$ 35.7 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031.
Published Date: 2025-05-12
Pages: 134
USD 3950.00
(Single User License)
The global market for High Purity Taxifolin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 96
USD 3950.00
(Single User License)
The global High Purity Taxifolin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-12
Pages: 93
USD 4900.00
(Single User License)
The global High Purity Taxifolin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 85
USD 2900.00
(Single User License)
The global High Purity Taxifolin market size was US$ 28.09 million in 2025 and is forecast to reach a readjusted size of US$ 36.97 million by 2032 with a CAGR of 4.1% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 80
The global High Purity Taxifolin market was valued at US$ 28.09 million in 2025 and is anticipated to reach US$ 36.97 million by 2032, at a CAGR of 4.1% from 2026 to 2032.
Published: 2026-01-05
Pages: 133
The global High Purity Taxifolin market size was US$ 26.7 million in 2024 and is forecast to a readjusted size of US$ 35.7 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 80
The global High Purity Taxifolin market is projected to grow from US$ 26.7 million in 2024 to US$ 35.7 million by 2031, at a CAGR of 4.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 150
The global High Purity Taxifolin market is projected to grow from US$ 28.1 million in 2025 to US$ 35.7 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.1% during the forecast period.
Published: 2025-05-23
Pages: 134
The global market for High Purity Taxifolin was valued at US$ 26.7 million in the year 2024 and is projected to reach a revised size of US$ 35.7 million by 2031, growing at a CAGR of 4.1% during the forecast period.
Published: 2025-05-23
Pages: 88
The global market for High Purity Taxifolin was estimated to be worth US$ 26.7 million in 2024 and is forecast to a readjusted size of US$ 35.7 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031.
Published: 2025-05-12
Pages: 134
The global market for High Purity Taxifolin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 96
The global High Purity Taxifolin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-12
Pages: 93
The global High Purity Taxifolin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 85
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now